StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.70+0.00 (0.00%)

Close on Nov 17, 2026Market cap $103.06MP/E –Yield –

Unicycive Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Unicycive Therapeutics's operating margin for the twelve months ending Dec 31, 2023 was -3077.6%. For fiscal 2023 it was -3077.6%, against -1898.2% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-3077.6%−1179.4
FY2022Dec 31, 2022-1898.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2023Mar 31, 2023-622.5%–
Q3 FY2022Sep 30, 2022-584.0%–

More Unicycive Therapeutics figures

See a number that looks wrong?